Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure

被引：67

作者：

Hognestad, A ^{[1
]}

Dickstein, K

Myhre, E

Snapinn, S

Kjekshus, J

机构：

[1] Univ Oslo, RIKEN, Dept Cardiol, N-0027 Oslo, Norway

[2] Cent Hosp Rogaland, Div Cardiol, Bergen, Norway

[3] Univ Bergen, N-5020 Bergen, Norway

[4] Sorlandet Hosp Kristiansand, Dept Cardiol, Tromso, Norway

[5] Univ Tromso, N-9001 Tromso, Norway

[6] Merck Res Labs, W Point, PA USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 05期

关键词：

D O I：

10.1016/j.amjcard.2003.11.027

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This retrospective, nonrandomized analysis evaluated the effect of initiating statin or beta-blocker treatment early in the course of heart failure developed during acute myocardial infarction compared with the effect of neither or both treatments. Early initiation of statins or beta blockers alone was associated with improved event-free survival, and the benefits of the combined treatment-were additive. (C)2004 by Excerpta Medica, Inc.

引用

收藏

页码：603 / 606

页数：4

相关论文

共 12 条

[1] Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial [J].

Dickstein, K ;

Kjekshus, J .

LANCET, 2002, 360 (9335) :752-760

[2] Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction:: The OPTIMAAL trial design [J].

Dickstein, K ;

Kjekshus, J .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (04) :477-481

[3]

Fonarow Gregg C, 2002, Rev Cardiovasc Med, V3 Suppl 3, pS2

[4]

FURBERG CD, 1989, HYPERTENSION S1, V13, P57

[5] Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness -: Main results from the β-blocker cholesterol-lowering asymptomatic plaque study (BCAPS) [J].

Hedblad, B ;

Wikstrand, J ;

Janzon, L ;

Wedel, H ;

Berglund, G .

CIRCULATION, 2001, 103 (13) :1721-1726

[6] Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease [J].

Majumdar, SR ;

Gurwitz, JH ;

Soumerai, SB .

JOURNAL OF GENERAL INTERNAL MEDICINE, 1999, 14 (12) :711-717

[7]

MEADE TW, 1992, BMJ-BRIT MED J, V304, P405

[8] β-adrenergic blockade in developing heart failure -: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling [J].

Prabhu, SD ;

Chandrasekar, B ;

Murray, DR ;

Freeman, GL .

CIRCULATION, 2000, 101 (17) :2103-2109

[9] Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure [J].

Rauchhaus, M ;

Koloczek, V ;

Volk, HD ;

Kemp, M ;

Niebauer, J ;

Francis, DP ;

Coats, AJS ;

Anker, SD .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 76 (2-3) :125-133

[10] Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease [J].

Sueta, CA ;

Chowdhury, M ;

Boccuzzi, SJ ;

Smith, SC ;

Alexander, CM ;

Londhe, A ;

Lulla, A ;

Simpson, RJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (09) :1303-1307